When will the FDA will approve the daratumumab treatment for smoldering multiple myeloma (SMM)?

About

Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest global organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure. Your support helps us provide a wide range of programs and services to the myeloma community in the areas of Research, Education, Support, and Advocacy. The International Myeloma Foundation is a 501(c)(3) organization. Learn more at https://www.myeloma.org